Viewing Study NCT03747120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-02-22 @ 4:10 AM
Study NCT ID: NCT03747120
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-27
First Post: 2018-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
Sponsor: University of Texas Southwestern Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None her2-positive breast cancer View
None Breast Cancer View
None Pembrolizumab View
None Immunotherapy View
None Neoadjuvant her2 targeted therapy View
None Trastuzumab View
None Pertuzumab View
None Paclitaxel View